Search Count: 70
All
Selected
![]() |
Tpx2 7-20 Fused To Aurora-A Residues 116-389, Covalently Modified On Cys290 By F104 (7-((Perfluorophenyl)Sulfonyl)-3-(Trifluoromethyl)-5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2026-03-18 Classification: TRANSFERASE Ligands: MG, ADP, A1JQV, GOL, PGE, MES |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.20 Å Release Date: 2025-10-22 Classification: IMMUNE SYSTEM Ligands: A1JNK, ADP |
![]() |
Organism: Synthetic construct, Acinetobacter baumannii acicu
Method: X-RAY DIFFRACTION Resolution:1.35 Å Release Date: 2025-09-17 Classification: PROTEIN BINDING |
![]() |
Organism: Synthetic construct, Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2025-09-17 Classification: DE NOVO PROTEIN |
![]() |
Incorporation Of Dehydro-Aza-Proline Residues In Avian Pancreatic Polypeptide: Prototype Sequence
Organism: Meleagris gallopavo
Method: SOLUTION NMR Release Date: 2025-04-02 Classification: SIGNALING PROTEIN |
![]() |
Incorporation Of Dehydro-Aza-Proline Residues In Avian Pancreatic Polypeptide: Aza-Pro Substitution At Position 4
Organism: Meleagris gallopavo
Method: SOLUTION NMR Release Date: 2025-04-02 Classification: SIGNALING PROTEIN |
![]() |
Incorporation Of Dehydro-Aza-Proline Residues In Avian Pancreatic Polypeptide: Aza-Pro Substitution At Position 6
Organism: Meleagris gallopavo
Method: SOLUTION NMR Release Date: 2025-04-02 Classification: SIGNALING PROTEIN |
![]() |
Incorporation Of Dehydro-Aza-Proline Residues In Avian Pancreatic Polypeptide: Aza-Pro Substitution At Positions 4 And 6
Organism: Meleagris gallopavo
Method: SOLUTION NMR Release Date: 2025-04-02 Classification: SIGNALING PROTEIN |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2024-12-11 Classification: IMMUNE SYSTEM Ligands: A1IPJ, ADP |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.70 Å Release Date: 2024-05-08 Classification: VIRAL PROTEIN |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2, Lama glama, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2024-05-08 Classification: VIRAL PROTEIN Ligands: NAG, GOL |
![]() |
Locally Refined Sars-Cov-2 Ba-2.86 Spike Receptor Binding Domain (Rbd) Complexed With Angiotensin Converting Enzyme 2 (Ace2)
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-05-08 Classification: VIRAL PROTEIN Ligands: NAG |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-05-08 Classification: VIRAL PROTEIN |
![]() |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:4.03 Å Release Date: 2024-05-08 Classification: VIRAL PROTEIN |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2, Tequatrovirus t4, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-05-08 Classification: VIRAL PROTEIN |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2023-12-27 Classification: SIGNALING PROTEIN |
![]() |
Crystal Structure Of The Tyk2 Pseudokinase Domain In Complex With Compound 8
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2023-07-26 Classification: TRANSFERASE Ligands: ZRU |
![]() |
Crystal Structure Of The Tyk2 Pseudokinase Domain In Complex With Compound 11
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.71 Å Release Date: 2023-07-26 Classification: TRANSFERASE Ligands: ZS3, EDO, ACT |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2023-07-26 Classification: TRANSFERASE Ligands: ZSB, ACT, EDO |
![]() |
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2023-06-07 Classification: SIGNALING PROTEIN Ligands: SO4, DYQ |




















